Histone/chromosome structure, Histone-lysine N-methyltransferase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Related structures:
AlphaFold database: A4ICW6
Term | Name | Level | Count |
---|---|---|---|
GO:0008152 | metabolic process | 1 | 2 |
GO:0032259 | methylation | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0000166 | nucleotide binding | 3 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0005524 | ATP binding | 5 | 2 |
GO:0008168 | methyltransferase activity | 4 | 2 |
GO:0008716 | D-alanine-D-alanine ligase activity | 5 | 2 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 2 |
GO:0016874 | ligase activity | 2 | 2 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 3 | 2 |
GO:0016881 | acid-amino acid ligase activity | 4 | 2 |
GO:0017076 | purine nucleotide binding | 4 | 2 |
GO:0030554 | adenyl nucleotide binding | 5 | 2 |
GO:0032553 | ribonucleotide binding | 3 | 2 |
GO:0032555 | purine ribonucleotide binding | 4 | 2 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 2 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 2 |
GO:0036094 | small molecule binding | 2 | 2 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043168 | anion binding | 3 | 2 |
GO:0043169 | cation binding | 3 | 2 |
GO:0046872 | metal ion binding | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0097367 | carbohydrate derivative binding | 2 | 2 |
GO:1901265 | nucleoside phosphate binding | 3 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 157 | 161 | PF00656 | 0.497 |
CLV_C14_Caspase3-7 | 18 | 22 | PF00656 | 0.526 |
CLV_NRD_NRD_1 | 130 | 132 | PF00675 | 0.487 |
CLV_NRD_NRD_1 | 297 | 299 | PF00675 | 0.506 |
CLV_NRD_NRD_1 | 314 | 316 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 326 | 328 | PF00675 | 0.275 |
CLV_NRD_NRD_1 | 461 | 463 | PF00675 | 0.406 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.358 |
CLV_PCSK_SKI1_1 | 233 | 237 | PF00082 | 0.371 |
CLV_PCSK_SKI1_1 | 358 | 362 | PF00082 | 0.271 |
CLV_PCSK_SKI1_1 | 469 | 473 | PF00082 | 0.559 |
CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.387 |
DEG_APCC_KENBOX_2 | 249 | 253 | PF00400 | 0.386 |
DOC_CYCLIN_yCln2_LP_2 | 136 | 142 | PF00134 | 0.312 |
DOC_CYCLIN_yCln2_LP_2 | 99 | 105 | PF00134 | 0.357 |
DOC_MAPK_gen_1 | 135 | 142 | PF00069 | 0.499 |
DOC_MAPK_gen_1 | 185 | 193 | PF00069 | 0.416 |
DOC_MAPK_gen_1 | 324 | 333 | PF00069 | 0.455 |
DOC_MAPK_MEF2A_6 | 185 | 193 | PF00069 | 0.399 |
DOC_PP1_RVXF_1 | 173 | 180 | PF00149 | 0.355 |
DOC_PP2B_LxvP_1 | 136 | 139 | PF13499 | 0.413 |
DOC_PP4_FxxP_1 | 397 | 400 | PF00568 | 0.540 |
DOC_USP7_MATH_1 | 194 | 198 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 206 | 210 | PF00917 | 0.534 |
DOC_USP7_MATH_1 | 366 | 370 | PF00917 | 0.484 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.498 |
DOC_USP7_UBL2_3 | 324 | 328 | PF12436 | 0.540 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.595 |
DOC_WW_Pin1_4 | 50 | 55 | PF00397 | 0.396 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.381 |
LIG_14-3-3_CanoR_1 | 143 | 151 | PF00244 | 0.533 |
LIG_14-3-3_CanoR_1 | 442 | 452 | PF00244 | 0.507 |
LIG_14-3-3_CanoR_1 | 95 | 100 | PF00244 | 0.416 |
LIG_APCC_ABBA_1 | 149 | 154 | PF00400 | 0.473 |
LIG_APCC_ABBA_1 | 308 | 313 | PF00400 | 0.539 |
LIG_BRCT_BRCA1_1 | 29 | 33 | PF00533 | 0.481 |
LIG_EH1_1 | 102 | 110 | PF00400 | 0.458 |
LIG_FHA_1 | 143 | 149 | PF00498 | 0.467 |
LIG_FHA_1 | 210 | 216 | PF00498 | 0.454 |
LIG_FHA_1 | 303 | 309 | PF00498 | 0.530 |
LIG_FHA_1 | 321 | 327 | PF00498 | 0.372 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.486 |
LIG_FHA_2 | 13 | 19 | PF00498 | 0.544 |
LIG_FHA_2 | 155 | 161 | PF00498 | 0.407 |
LIG_FHA_2 | 246 | 252 | PF00498 | 0.512 |
LIG_FHA_2 | 283 | 289 | PF00498 | 0.372 |
LIG_FHA_2 | 357 | 363 | PF00498 | 0.464 |
LIG_FHA_2 | 421 | 427 | PF00498 | 0.316 |
LIG_LIR_Apic_2 | 349 | 355 | PF02991 | 0.501 |
LIG_LIR_Apic_2 | 361 | 366 | PF02991 | 0.394 |
LIG_LIR_Gen_1 | 339 | 348 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 418 | 429 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 55 | 63 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 232 | 237 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 339 | 343 | PF02991 | 0.451 |
LIG_LIR_Nem_3 | 359 | 363 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 418 | 424 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.452 |
LIG_SH2_NCK_1 | 112 | 116 | PF00017 | 0.368 |
LIG_SH2_SRC | 112 | 115 | PF00017 | 0.405 |
LIG_SH2_STAP1 | 401 | 405 | PF00017 | 0.385 |
LIG_SH2_STAP1 | 57 | 61 | PF00017 | 0.246 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.378 |
LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.412 |
LIG_SH3_3 | 112 | 118 | PF00018 | 0.426 |
LIG_SH3_3 | 259 | 265 | PF00018 | 0.433 |
LIG_SH3_3 | 340 | 346 | PF00018 | 0.453 |
LIG_SH3_3 | 467 | 473 | PF00018 | 0.451 |
LIG_SUMO_SIM_anti_2 | 104 | 109 | PF11976 | 0.458 |
LIG_TYR_ITIM | 110 | 115 | PF00017 | 0.476 |
LIG_UBA3_1 | 166 | 175 | PF00899 | 0.292 |
LIG_WRC_WIRS_1 | 421 | 426 | PF05994 | 0.307 |
MOD_CK1_1 | 209 | 215 | PF00069 | 0.348 |
MOD_CK1_1 | 229 | 235 | PF00069 | 0.445 |
MOD_CK1_1 | 282 | 288 | PF00069 | 0.582 |
MOD_CK2_1 | 12 | 18 | PF00069 | 0.493 |
MOD_CK2_1 | 245 | 251 | PF00069 | 0.499 |
MOD_CK2_1 | 282 | 288 | PF00069 | 0.527 |
MOD_CK2_1 | 356 | 362 | PF00069 | 0.477 |
MOD_CK2_1 | 52 | 58 | PF00069 | 0.423 |
MOD_GlcNHglycan | 228 | 231 | PF01048 | 0.334 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.517 |
MOD_GlcNHglycan | 445 | 448 | PF01048 | 0.429 |
MOD_GlcNHglycan | 465 | 468 | PF01048 | 0.444 |
MOD_GlcNHglycan | 66 | 70 | PF01048 | 0.619 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.463 |
MOD_N-GLC_1 | 181 | 186 | PF02516 | 0.463 |
MOD_N-GLC_1 | 387 | 392 | PF02516 | 0.229 |
MOD_N-GLC_2 | 144 | 146 | PF02516 | 0.387 |
MOD_N-GLC_2 | 62 | 64 | PF02516 | 0.305 |
MOD_NEK2_1 | 279 | 284 | PF00069 | 0.429 |
MOD_NEK2_1 | 289 | 294 | PF00069 | 0.429 |
MOD_NEK2_1 | 320 | 325 | PF00069 | 0.546 |
MOD_NEK2_1 | 356 | 361 | PF00069 | 0.538 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.318 |
MOD_NEK2_2 | 194 | 199 | PF00069 | 0.492 |
MOD_NEK2_2 | 425 | 430 | PF00069 | 0.346 |
MOD_NEK2_2 | 78 | 83 | PF00069 | 0.458 |
MOD_PIKK_1 | 1 | 7 | PF00454 | 0.446 |
MOD_PKA_2 | 142 | 148 | PF00069 | 0.461 |
MOD_Plk_1 | 162 | 168 | PF00069 | 0.472 |
MOD_Plk_1 | 415 | 421 | PF00069 | 0.455 |
MOD_Plk_1 | 456 | 462 | PF00069 | 0.402 |
MOD_Plk_2-3 | 154 | 160 | PF00069 | 0.277 |
MOD_Plk_2-3 | 415 | 421 | PF00069 | 0.424 |
MOD_Plk_4 | 162 | 168 | PF00069 | 0.400 |
MOD_Plk_4 | 289 | 295 | PF00069 | 0.477 |
MOD_Plk_4 | 456 | 462 | PF00069 | 0.482 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.337 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.347 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.591 |
MOD_ProDKin_1 | 50 | 56 | PF00069 | 0.395 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.376 |
TRG_DiLeu_BaLyEn_6 | 467 | 472 | PF01217 | 0.546 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.358 |
TRG_ENDOCYTIC_2 | 421 | 424 | PF00928 | 0.307 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.441 |
TRG_Pf-PMV_PEXEL_1 | 168 | 172 | PF00026 | 0.402 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILG6 | Leptomonas seymouri | 66% | 100% |
A0A0S4JLQ2 | Bodo saltans | 27% | 100% |
A0A0S4KKY2 | Bodo saltans | 42% | 100% |
A0A1X0P8J8 | Trypanosomatidae | 42% | 100% |
A0A3Q8IJR2 | Leishmania donovani | 100% | 100% |
A0A3R7MWC4 | Trypanosoma rangeli | 26% | 92% |
A0A3R7P2U3 | Trypanosoma rangeli | 39% | 100% |
A4HNM9 | Leishmania braziliensis | 83% | 100% |
D0A2I3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
E9ASD8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q257 | Leishmania major | 92% | 100% |
V5BQK1 | Trypanosoma cruzi | 39% | 100% |